Intracellular signaling pathways in Peripheral Blood Mononuclear Cells in patients with inflammatory bowel disease.

Intracellular signaling pathways in Peripheral Blood Mononuclear Cells in patients with inflammatory bowel disease. - Inflammatory bowel disease and intracellular signaling pathways

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29966

Enrollment

Registered

2006-09-22

Start date

2006-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohns disease ileitis terminalis inflammatory bowel disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Crohn patients in remission, with (n

Exclusion criteria

Exclusion criteria: Patients suffering from active disease, patient using immunesuppressive therapy other than azathioprine

Design outcomes

Primary

Measure	Time frame
Signal intensity on Western Blots 0, 5, 30 en 60 minutes after stimulation with TNF-alfa or complement factor 5a.	—

Countries

Netherlands

Outcome results